Member Info for Nolupus

LimaLiam,
I just asked a question, one that I have not got an answer to , yet

Maybe investor relations might answer the question , one of these days …

I should have specified the Lupuzor Lupus patent …

When is that one due to run out ?

Mister positive,

Very interesting figures !

10 years of royalties could bring in 1,5 billion ?

Could you tell us when the Lupuzor patents run out, please ?

GSK and AZ

A bit of reading on the current state of the market

https://www.fiercepharma.com/pharma/astrazeneca-nabs-fda-nod-to-challenge-gsk-s-benlysta-first-class-lupus-drug-saphnelo

Great experts …

Thanks for making me smile ??

My picks

Stx
Dnl
EVG

Bojo2020,

Heads were on the chopping board :-)

It’s going to be interesting to see who will take on the CEO job ..

Pump and dump crew back again?

IMM is in a much different situation than in 2018, when they were preparing for the P3 readout with the full world rights to an open market for Lupus patients .
Astra has since been approved and Benlysta has improved their mode of administration ..
IMM signed away the US rights ..

So comparing 2018 to 2022 does’nt make any sense to me , as IMM have still to get approval to do the new P3 study and when they do , it will be years before the readout …

Many things will have changed in the meantime, imo

For the brave who have deep pockets and can wait for ´normality ´ to come back …

Like always , the market will correct sometime in the future

Sng
Iqai
Evg

Buy the dips and sell the highs …

Moving fast today …but still that resistance level of 33-35p to be passed

Troajan,

no research needed,just good luck and a strong nerve.lol

I don’t really agree with that statement , when one has done their research they know when the stock is well well oversold … all one needs is cash to buy :-)
And to watch the support and resistance levels …

Some of us will be watching the 33-35p level …

If we can get past that well …

The drop is overdone , so bought some for the swing trade

But everyone to their own …

https://endpts.com/putting-its-pivotal-failure-in-the-rearview-mirror-astrazeneca-scores-an-eu-nod-for-its-lupus-drug/

Xviolet,

One has to be careful and objective whilst investing ..
Covid stocks are ´ has been ´ at the moment as the market seems to think that we are out of the woods on the pandemic…
EUA may be authorized but full approval needs to be backed up with solid results from P3 trials and after a full filling etc etc ( usually takes up to a year )

Timing is the key , in biotech investing , so if you get it right , you can make a fortune but if you get it wrong , one can lose a fortune …

Will go with the same 3 again , thanks for the effort involved in keeping the competition going :-)

https://endpts.com/nasal-sprays-to-stave-off-viruses-days-at-a-time-jjs-newest-biotech-partner-draws-140m-for-proactive-approach/

Where hais MAverickD gone to ?

Needs a bit of pumping , imo